Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
clinical trials
life sciences
national blog main
alnylam pharmaceuticals
boston
boston blog main
boston top stories
drugs
fda
rna interference
aminolevulinic acid
givosiran
onpattro
patisiran
san francisco blog main
san francisco top stories
a2a pharmaceuticals
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
akcea therapeutics
akin akinc
andrew fire
artificial intelligence
atea pharmaceuticals
big data
business
cannabidiol
category-/health/health conditions
cloud
coronavirus
covid-19
craig mello
dev
dravet syndrome
enterprise
epidiolex
fen-phen
fenfluramine
gw pharmaceuticals
What
drug
7
×
medicine
7
×
pharmaceuticals
7
×
fda
new
alnylam
approved
rnai
ago
cure
data
far
interference
market
ok
rare
rna
second
seek
speedy
weeks
aa
adamis
administration
advances
afternoon
allergy
alnylam’s
alternative
announced
antiviral
applying
approval
artificial
atea
battle
cannabis
cheaper
clear
cleared
Language
unset
Current search:
pharmaceuticals
×
drug
×
medicine
×
photo
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@venturebeat.com
5 years ago
Consortium.AI wants to cure rare diseases using artificial intelligence
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@theverge.com
6 years ago
Cheaper alternative to EpiPen allergy shot approved by FDA